Gilead Sciences, Inc.
GILD
$125.00
$1.090.88%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.72% | 6.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.70% | 6.22% | |||
| Cost of Revenue | 4.53% | -2.53% | |||
| Gross Profit | 11.09% | 8.86% | |||
| SG&A Expenses | -0.44% | 11.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.25% | 5.07% | |||
| Operating Income | 26.72% | 8.07% | |||
| Income Before Tax | 49.96% | 47.24% | |||
| Income Tax Expenses | 25.85% | 40.12% | |||
| Earnings from Continuing Operations | 55.71% | 49.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 55.71% | 49.05% | |||
| EBIT | 26.72% | 8.07% | |||
| EBITDA | 21.25% | 6.19% | |||
| EPS Basic | 55.96% | 49.17% | |||
| Normalized Basic EPS | 29.61% | 7.61% | |||
| EPS Diluted | 55.77% | 50.00% | |||
| Normalized Diluted EPS | 29.50% | 7.88% | |||
| Average Basic Shares Outstanding | -0.16% | -0.08% | |||
| Average Diluted Shares Outstanding | -0.08% | -0.32% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.35% | -0.34% | |||